Woodford Investment Management’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-300,040
Closed -$70.9M 8
2019
Q1
$70.9M Buy
300,040
+73,476
+32% +$23.1M 5.73% 6
2018
Q4
$68.2M Sell
226,564
-68,000
-23% -$21.7M 5.9% 6
2018
Q3
$104M Buy
294,564
+15,000
+5% +$5.16M 8.29% 5
2018
Q2
$81.1M Hold
279,564
9.84% 4
2018
Q1
$76.5M Sell
279,564
-91,000
-25% -$28.2M 6.81% 4
2017
Q4
$118M Buy
370,564
+10,480
+3% +$3.36M 7.96% 4
2017
Q3
$113M Sell
360,084
-8,561
-2% -$2.54M 5.18% 6
2017
Q2
$100M Sell
368,645
-8,143
-2% -$2.15M 3.67% 7
2017
Q1
$103M Buy
376,788
+128,258
+52% +$36.3M 4.26% 6
2016
Q4
$64.9M Buy
248,530
+78,100
+46% +$23.2M 3.13% 5
2016
Q3
$53.4M Buy
170,430
+150,430
+752% +$44.6M 2.16% 6
2016
Q2
$4.84M Buy
+20,000
New +$5.27M 0.23% 7

Other funds holding BIIB

Woodford Investment Management's BIIB Position: Q2 2019 in Review

Woodford Investment Management sold out of Biogen (BIIB) in Q2 2019, closing a stake of 300,040 shares — an estimated $70.9M sold.

Woodford Investment Management first reported a position in BIIB in Q2 2016 and held it in 12 quarters. The position peaked at $118M in Q4 2017. 1,010 funds tracked by Wall St. Rank hold BIIB as of Q2 2019.

  • Woodford Investment Management reported no remaining Biogen position as of Q2 2019 after selling out during the quarter.
  • Woodford Investment Management sold 300,040 Biogen shares in Q2 2019, an estimated $70.9M.
  • Woodford Investment Management first reported a position in Biogen in Q2 2016 and held it in 12 quarters.
  • Woodford Investment Management's Biogen position peaked at $118M in Q4 2017.
  • 1,010 funds tracked by Wall St. Rank held Biogen as of Q2 2019.

Based on Woodford Investment Management's 13F filing for Q2 2019, filed 14 Aug 2019.